2R,3R)-rel-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol hydrochloride

We are 2R,3R)-rel-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol hydrochloride CAS:175590-75-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(2R,3R)-rel-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol hydrochloride
CAS.NO:175590-75-7
Synonyms:(2R,3R)-rel-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol hydrochloride
(2R,3R)-3-(3-Methoxyphenyl)-N,N,2-trimethylpentanamine hydrochloride
 
Physical and Chemical Properties:
Molecular Formula C15H26ClNO
Molecular Weight 271.82600
 
Specification:
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Tapentadol(CAS:175591-23-8) and Tapentadol Hydrochloride(CAS:175591-09-0).

2R,3R)-rel-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol hydrochloride


Related News: A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.Sulfato de 8-hidroxiquinolina CAS:134-31-6 However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.2- (4-bromofenil) -1-fenilbencimidazol CAS:2620-76-0 However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.2'-Chloroacetoacetanilide CAS:93-70-9 The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.

Related Products
Product Name
Bis(4-biphenylyl)amine View Details
Ethyl linolenate View Details
4-chlorobenzoyl chloride View Details
Cytidine 5′-monophosphate disodium salt manufacturer 3-(3-methoxyphenyl)-N,N,2-trimethylpentanamide manufacturer Hydroxytyrosol manufacturer (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole manufacturer (R)-1-(3,5-Bis-Trifluoromethyl-Phenyl)-Ethanol manufacturer